Canlyniadau Chwilio - Takayuki Yoshino
- Dangos 1 - 20 canlyniadau o 152
- Ewch i'r Dudalen Nesaf
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors gan Yoshiaki Nakamura, Takao Fujisawa, Hiroya Taniguchi, Hideaki Bando, Wataru Okamoto, Katsuya Tsuchihara, Takayuki Yoshino, Atsushi Ohtsu
Cyhoeddwyd 2021Revisão -
10
Prevalence of <i>KRAS</i> G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review gan John H. Strickler, Takayuki Yoshino, Kendall Stevinson, C. Eichinger, Christina Giannopoulou, Marko Rehn, Dominik Paul Modest
Cyhoeddwyd 2023Revisão -
11
Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers gan Monica Augustyniak, Emil Lou, Ginny Jacobs, Matthew R. Fleming, John Marshall, Anelisa K. Coutinho, Takayuki Yoshino
Cyhoeddwyd 2023Artigo -
12
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay gan Tadayoshi Hashimoto, Yoshiaki Nakamura, Eiji Oki, Shin Kobayashi, Junichiro Yuda, Taro Shibuki, Hideaki Bando, Takayuki Yoshino
Cyhoeddwyd 2024Artigo -
13
-
14
New diagnostic method based on color imaging using narrow band imaging (NBI) system for gastrointestinal tract gan Yasushi Sano, Masahiko Kobayashi, Yasuo Hamamoto, Shigeharu Kato, Kuang‐I Fu, Takayuki Yoshino, Shigeaki Yoshida, Takahiro Kozu, Takahiro Fujii
Cyhoeddwyd 2001Artigo -
15
Japanese Society of Medical Oncology Clinical Guidelines: <i><scp>RAS</scp></i> (<i><scp>KRAS</scp>/<scp>NRAS</scp></i>) mutation testing in colorectal cancer patients gan Hiroya Taniguchi, Kentaro Yamazaki, Takayuki Yoshino, Kei Muro, Yasushi Yatabe, Toshiaki Watanabe, Hiromichi Ebi, Atsushi Ochiai, Eishi Baba, Katsuya Tsuchihara
Cyhoeddwyd 2015Artigo -
16
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study gan Pashtoon Murtaza Kasi, Daisuke Kotani, Michael Cecchini, Kohei Shitara, Atsushi Ohtsu, Ramesh K. Ramanathan, Howard S. Höchster, Axel Grothey, Takayuki Yoshino
Cyhoeddwyd 2016Artigo -
17
P-275 First-line pembrolizumab versus investigator-choice chemotherapy for mismatch repair–deficient or microsatellite instability–high metastatic colorectal carcinoma: randomized,... gan Luis, Diaz, Dung, Le, Takayuki, Yoshino, Thierry, André, Johanna, Bendell, Minori, Koshiji, Yinghua, Zhang, Peter, Kang S., Bao, Lam, Dirk, Jäger
Cyhoeddwyd 2016Text -
18
Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer gan Yasutoshi Kuboki, Satoshi Yamashita, Tohru Niwa, Toshikazu Ushijima, Akiko Kawano Nagatsuma, Takeshi Kuwata, Takayuki Yoshino, Toshihiko Doi, Atsushi Ochiai, Atsushi Ohtsu
Cyhoeddwyd 2015Artigo -
19
Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric... gan Akihito Kawazoe, Takeshi Kuwata, Yasutoshi Kuboki, Kohei Shitara, Akiko Kawano Nagatsuma, Masaaki Aizawa, Takayuki Yoshino, Toshihiko Doi, Atsushi Ohtsu, Atsushi Ochiai
Cyhoeddwyd 2016Artigo -
20
Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma gan Ken Hatogai, Shigehisa Kitano, Satoshi Fujii, Takashi Kojima, Hiroyuki Daiko, Shogo Nomura, Takayuki Yoshino, Atsushi Ohtsu, Yuichi Takiguchi, Toshihiko Doi, Atsushi Ochiai
Cyhoeddwyd 2016Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Biology
Gene
Chemotherapy
Pathology
Genetics
Gastroenterology
Confidence interval
Cancer research
Clinical trial
Clinical endpoint
Family medicine
Hazard ratio
Randomized controlled trial
Surgery
Allele
KRAS
Microsatellite
Microsatellite instability
Clinical Practice
Immunotherapy
Adverse effect
Alternative medicine
Biochemistry
Breast cancer
Oxaliplatin